BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29924226)

  • 1. Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome.
    Merlotto MR; Cantadori LO; Sakabe D; Miot HA
    An Bras Dermatol; 2018 Jun; 93(3):451-453. PubMed ID: 29924226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypereosinophilic syndrome with unusual cutaneous manifestations in two men with HIV infection.
    May LP; Kelly J; Sanchez M
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):202-4. PubMed ID: 2145324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report.
    Yamamoto M; Ikuta K; Toki Y; Hatayama M; Shindo M; Torimoto Y; Okumura T
    Medicine (Baltimore); 2017 Sep; 96(36):e8001. PubMed ID: 28885361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case report.
    Granjo E; Lima M; Lopes JM; Dória S; Orfão A; Ying S; Barata LT; Miranda M; Cross NC; Bain BJ
    Acta Haematol; 2002; 107(2):108-12. PubMed ID: 11919392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated symptomatic cutaneous disease in hypereosinophilic syndrome.
    Preda V; Henderson C; Woods J
    Australas J Dermatol; 2010 Feb; 51(1):60-5. PubMed ID: 20148847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypereosinophilia associated with increased serum levels of carcinoembryonic antigen.
    Iwata H; Tsuboi N; Ishii T; Hara Y; Okido I; Takahashi H; Kawamura T; Hosoya T
    Intern Med; 2008; 47(10):963-7. PubMed ID: 18480583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic hypereosinophilic syndrome: a rare cause of erythroderma.
    Mahajan VK; Singh R; Mehta KS; Chauhan PS; Sharma S; Gupta M; Rawat R
    J Dermatol Case Rep; 2014 Dec; 8(4):108-14. PubMed ID: 25621091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypereosinophilic syndrome preceding a diagnosis of B-cell lymphoma.
    Samarghandi A; Ahuja S; Jindal V; Gupta S; Fulger I
    Tumori; 2018 Dec; 104(6):NP22-NP24. PubMed ID: 29714651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized Recalcitrant Pruritus as the Presenting Manifestation of Hypereosinophilic Syndrome.
    Schreiber A; LeBlanc M; Thibeault MM; Mathieu S
    J Cutan Med Surg; 2016 Jul; 20(4):346-8. PubMed ID: 26826106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus infection and hypereosinophilic syndrome. An increasingly recognized association.
    Morgan MB; Viloria J; Morgan JD; Suarez-Hoyos J
    J Fla Med Assoc; 1994 Jun; 81(6):401-2. PubMed ID: 8064280
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute exacerbation of idiopathic hypereosinophilic syndrome following asymptomatic coronavirus disease 2019: a case report.
    Suzuki S; Suzuki K; Ichikawa T; Takahashi K; Minami-Hori M; Tanino Y
    J Med Case Rep; 2022 Aug; 16(1):324. PubMed ID: 36042524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
    Hofmann SC; Technau K; Müller AM; Lübbert M; Bruckner-Tuderman L
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S68-72. PubMed ID: 17097375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel subtype of myeloproliferative disorder? JAK2V617F-associated hypereosinophilia with hepatic venous thrombosis.
    Dasari S; Naha K; Hande M; Vivek G
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23997080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient left ventricular clot in COVID-19-related myocarditis is associated with hypereosinophilic syndrome: a case report.
    Ziaie N; Maleh PA; Ramandi MMA; Pourkia R; Latifi K; Mansouri D
    Int J Cardiovasc Imaging; 2021 Nov; 37(11):3279-3283. PubMed ID: 34160722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Hypereosinophilic Syndromes.
    Roufosse F
    Immunol Allergy Clin North Am; 2015 Aug; 35(3):561-75. PubMed ID: 26209900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency of imatinib in polyserositis revealing a FIP1L1-PDGFRA-negative hypereosinophilic syndrome].
    Green L; Kahn JE; Dufour JF; Le Scanff J; Charhon A; Broussolle C; Sève P
    Rev Med Interne; 2010 Apr; 31(4):305-8. PubMed ID: 20167399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Lymphocytic Variant of Hypereosinophilic Syndrome Presenting With Isolated Cutaneous Manifestations.
    Kamal Idrissi O; Hali F; El Fatoiki F; Chiheb S
    Cureus; 2022 Sep; 14(9):e29745. PubMed ID: 36340564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and Differential Diagnosis of Persistent Marked Eosinophilia.
    Curtis C; Ogbogu PU
    Immunol Allergy Clin North Am; 2015 Aug; 35(3):387-402. PubMed ID: 26209891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature.
    Voeller J; DeNapoli T; Griffin TC
    Cancer Rep (Hoboken); 2022 Nov; 5(11):e1710. PubMed ID: 36241191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypereosinophilic syndrome: endomyocardial biopsy versus echocardiography to diagnose cardiac involvement.
    Butterfield JH; Kane GC; Weiler CR
    Postgrad Med; 2017 Jun; 129(5):517-523. PubMed ID: 28440714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.